肾功能衰竭患者的髋关节置换术结局:一项全国数据关联研究
该研究利用澳大利亚两个全国性登记库(透析与肾移植登记库、全髋关节置换术登记库)关联数据,比较透析患者、有功能肾移植患者及无肾衰竭患者初次全髋关节置换术后的翻修率和死亡率。共纳入383,478例初次全髋关节置换术(透析组490例、有功能肾移植组459例、无肾衰竭组382,529例)。结果显示三组间总体翻修率无显著差异,但透析组术后死亡风险显著高于有功能肾移植组和无肾衰竭组。
要点
- 透析组与无肾衰竭组总体翻修率无显著差异(HR=1.20;95%CI 0.76, 1.88)。
- 有功能肾移植组与无肾衰竭组总体翻修率无显著差异(HR=1.01;95%CI 0.66, 1.53)。
- 透析组术后死亡风险显著高于有功能肾移植组(HR=3.44;95%CI 1.58, 7.5)和无肾衰竭组(HR=4.13;95%CI 3.25, 5.25)。
核心结论
- 透析患者全髋关节置换术后死亡率高于有功能肾移植患者和无肾衰竭患者,但无早期超额死亡率提示该指标差异源于手术。
研究设计与样本
- 数据关联研究,使用澳大利亚透析与肾移植登记库及全髋关节置换术登记库数据,覆盖1999年9月至2016年12月几乎全部相关操作或治疗。
- 共纳入383,478例初次全髋关节置换术,其中透析组490例、有功能肾移植组459例、无肾衰竭组382,529例。
- 采用Cox回归和Fine-Gray竞争风险回归模型比较透析组、有功能肾移植组与无肾衰竭组的死亡率和翻修手术率。
主要发现
- 总体翻修率:透析组 vs 无肾衰竭组 HR=1.20(95%CI 0.76, 1.88),无显著差异;有功能肾移植组 vs 无肾衰竭组 HR=1.01(95%CI 0.66, 1.53),无显著差异。
- 术后死亡风险:透析组 vs 有功能肾移植组 HR=3.44(95%CI 1.58, 7.5),透析组显著更高;透析组 vs 无肾衰竭组 HR=4.13(95%CI 3.25, 5.25),透析组显著更高。
关键数值与推荐
- 透析组 vs 无肾衰竭组总体翻修率 HR=1.20(95%CI 0.76, 1.88)。
- 有功能肾移植组 vs 无肾衰竭组总体翻修率 HR=1.01(95%CI 0.66, 1.53)。
- 透析组 vs 有功能肾移植组术后死亡风险 HR=3.44(95%CI 1.58, 7.5)。
- 透析组 vs 无肾衰竭组术后死亡风险 HR=4.13(95%CI 3.25, 5.25)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who have kidney failure are at higher risk of requiring total hip arthroplasty (THA) and are at higher risk of complications. This study compared the rate of revision surgery and mortality following THA between patients who have kidney failure receiving long term dialysis or who had a kidney transplant and those who did not have kidney failure. METHODS: A data linkage study was performed using data from 2 national registries: a registry of dialysis and kidney transplant patients and a registry of THA procedures. Both registries had coverage of almost all procedures or treatments in Australia. Data from September 1999 to December 2016 were used. Mortality and revision surgery were compared between patients receiving dialysis, those who had a functioning kidney transplant, and patients who did not have kidney failure using Cox and Fine-Gray (competing risk) regression models. A total of 383,478 primary THA procedures were identified as people receiving dialysis (n = 490), who had a functioning kidney transplant (n = 459), or who did not have kidney failure (n = 382,529). RESULTS: There was no significant difference in the overall rate of revision surgery between the groups (dialysis versus no kidney failure HR = 1.20; 95% CI 0.76, 1.88, transplant versus no kidney failure (hazard ratio) HR = 1.01; 95% (confidence interval) CI 0.66, 1.53). The risk for death after surgery was significantly higher in the dialysis group compared to both the functioning transplant group (HR = 3.44; 95%CI 1.58, 7.5), and in those without kidney failure (HR = 4.13; 95%CI 3.25, 5.25). CONCLUSION: The rate of mortality after THA in patients on dialysis is higher than in patients who have a functioning transplant or those who do not have kidney failure, but there is no early excess mortality to suggest a difference in this metric due to the surgery.
引用
- Harris IA, Lorimer MF, Davies CE, et al. Hip Arthroplasty Outcomes in the Presence of Kidney Failure: A National Data Linkage Study. J Arthroplasty. 2023. PMID: 36708938. doi:10.1016/j.arth.2023.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。